Dr. Kara Spiller is the URBN Endowed Professor of Biomedical Innovation in Drexel University's School of Biomedical Engineering, Science, and Health Systems. Her research focuses on the role of immune cells in tissue repair and regeneration and the design of immunomodulatory biomaterials. Her research is funded by the NIH, the NSF, private foundations, and industry. Her awards include a Fulbright fellowship, the NSF CAREER award, and the United States Dept. of State ASPIRE prize. She has published more than 80 publications in biomaterials and immune engineering, and has 18 issued or pending patents. She is the founding director of the Immune Modulation & Engineering Symposium series in Philadelphia, which is the only annually recurring meeting dedicated to convergent research in translational immunology and engineering, and she directs multiple undergraduate and graduate programs focused on advanced therapeutics at Drexel University. She serves on the board of numerous journals and is a frequent ad hoc study section member.